55 related articles for article (PubMed ID: 20015089)
21. Characterization of N,N,-dimethyl-D-erythro-sphingosine-induced apoptosis and signaling in U937 cells: independence of sphingosine kinase inhibition.
Kim HL; Sacket SJ; Han M; Im DS
Prostaglandins Other Lipid Mediat; 2008 Jun; 86(1-4):18-25. PubMed ID: 18316219
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of vascular smooth muscle cell proliferation and neointimal formation in injured arteries by a novel, oral mitogen-activated protein kinase/extracellular signal-regulated kinase inhibitor.
Gennaro G; Ménard C; Michaud SE; Deblois D; Rivard A
Circulation; 2004 Nov; 110(21):3367-71. PubMed ID: 15520324
[TBL] [Abstract][Full Text] [Related]
23. Novel role of Egr-1 in nicotine-related neointimal formation.
Vazquez-Padron RI; Mateu D; Rodriguez-Menocal L; Wei Y; Webster KA; Pham SM
Cardiovasc Res; 2010 Nov; 88(2):296-303. PubMed ID: 20615913
[TBL] [Abstract][Full Text] [Related]
24. Baicalein attenuates intimal hyperplasia after rat carotid balloon injury through arresting cell-cycle progression and inhibiting ERK, Akt, and NF-kappaB activity in vascular smooth-muscle cells.
Peng CY; Pan SL; Huang YW; Guh JH; Chang YL; Teng CM
Naunyn Schmiedebergs Arch Pharmacol; 2008 Dec; 378(6):579-88. PubMed ID: 18663431
[TBL] [Abstract][Full Text] [Related]
25. Role of sphingosine kinases and lipid phosphate phosphatases in regulating spatial sphingosine 1-phosphate signalling in health and disease.
Pyne S; Lee SC; Long J; Pyne NJ
Cell Signal; 2009 Jan; 21(1):14-21. PubMed ID: 18768158
[TBL] [Abstract][Full Text] [Related]
26. The role of sphingosine kinase and sphingosine-1-phosphate in the regulation of endothelial cell biology.
Limaye V
Endothelium; 2008; 15(3):101-12. PubMed ID: 18568950
[TBL] [Abstract][Full Text] [Related]
27. Sphingosine 1-phosphate, lysophosphatidic acid and growth factor signaling and termination.
Pyne NJ; Pyne S
Biochim Biophys Acta; 2008 Sep; 1781(9):467-76. PubMed ID: 18558100
[TBL] [Abstract][Full Text] [Related]
28. "Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets.
Takabe K; Paugh SW; Milstien S; Spiegel S
Pharmacol Rev; 2008 Jun; 60(2):181-95. PubMed ID: 18552276
[TBL] [Abstract][Full Text] [Related]
29. Sphingosine-1-phosphate receptor subtypes differentially regulate smooth muscle cell phenotype.
Wamhoff BR; Lynch KR; Macdonald TL; Owens GK
Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1454-61. PubMed ID: 18535287
[TBL] [Abstract][Full Text] [Related]
30. Safety of drug-eluting stents.
Windecker S; Jüni P
Nat Clin Pract Cardiovasc Med; 2008 Jun; 5(6):316-28. PubMed ID: 18414453
[TBL] [Abstract][Full Text] [Related]
31. Principles of bioactive lipid signalling: lessons from sphingolipids.
Hannun YA; Obeid LM
Nat Rev Mol Cell Biol; 2008 Feb; 9(2):139-50. PubMed ID: 18216770
[TBL] [Abstract][Full Text] [Related]
32. Biological effects of drug-eluting stents in the coronary circulation.
Steffel J; Tanner FC
Herz; 2007 Jun; 32(4):268-73. PubMed ID: 17607532
[TBL] [Abstract][Full Text] [Related]
33. Regulation and functional roles of sphingosine kinases.
Alemany R; van Koppen CJ; Danneberg K; Ter Braak M; Meyer Zu Heringdorf D
Naunyn Schmiedebergs Arch Pharmacol; 2007 Feb; 374(5-6):413-28. PubMed ID: 17242884
[TBL] [Abstract][Full Text] [Related]
34. Locally administered antiproliferative drugs inhibit hypercontractility to serotonin in balloon-injured pig coronary artery.
Kennedy S; Wadsworth RM; Wainwright CL
Vascul Pharmacol; 2006 May; 44(5):363-71. PubMed ID: 16540378
[TBL] [Abstract][Full Text] [Related]
35. SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism.
Maceyka M; Sankala H; Hait NC; Le Stunff H; Liu H; Toman R; Collier C; Zhang M; Satin LS; Merrill AH; Milstien S; Spiegel S
J Biol Chem; 2005 Nov; 280(44):37118-29. PubMed ID: 16118219
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and evaluation of sphingoid analogs as inhibitors of sphingosine kinases.
Kim JW; Kim YW; Inagaki Y; Hwang YA; Mitsutake S; Ryu YW; Lee WK; Ha HJ; Park CS; Igarashi Y
Bioorg Med Chem; 2005 May; 13(10):3475-85. PubMed ID: 15848761
[TBL] [Abstract][Full Text] [Related]
37. High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors.
Kimura T; Sato K; Malchinkhuu E; Tomura H; Tamama K; Kuwabara A; Murakami M; Okajima F
Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1283-8. PubMed ID: 12775579
[TBL] [Abstract][Full Text] [Related]
38. Sphingosine-1-phosphate: an enigmatic signalling lipid.
Spiegel S; Milstien S
Nat Rev Mol Cell Biol; 2003 May; 4(5):397-407. PubMed ID: 12728273
[TBL] [Abstract][Full Text] [Related]
39. Signalling mechanisms in sphingosine 1-phosphate-promoted mesangial cell proliferation.
Katsuma S; Hada Y; Ueda T; Shiojima S; Hirasawa A; Tanoue A; Takagaki K; Ohgi T; Yano J; Tsujimoto G
Genes Cells; 2002 Dec; 7(12):1217-30. PubMed ID: 12485162
[TBL] [Abstract][Full Text] [Related]
40. D-erythro-N,N-dimethylsphingosine inhibits bFGF-induced proliferation of cerebral, aortic and coronary smooth muscle cells.
Xu CB; Zhang Y; Stenman E; Edvinsson L
Atherosclerosis; 2002 Oct; 164(2):237-43. PubMed ID: 12204793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
